Mirtazapine Treatment for Comorbid Anxiety/Depressive Disorders in Young Subjects with Attention-Deficit Hyperactivity Disorder: Case Series

---

Coskun M., AHMETOĞLU E., Ozturk M.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.20, no.3, pp.246-251, 2010 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 20 Issue: 3
• Publication Date: 2010
• Doi Number: 10.1080/10177833.2010.11790666
• Journal Name: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), TR DİZİN (ULAKBİM)
• Page Numbers: pp.246-251
• Keywords: Anxiety, ADHD, depression, comorbidity, mirtazapine, treatment, DEFICIT/HYPERACTIVITY DISORDER, OPEN-LABEL, PSYCHIATRIC COMORBIDITY, SLEEP PROBLEMS, CHILDREN, ANXIETY, ADOLESCENTS, ATOMOXETINE, DEPRESSION, FLUOXETINE
• Istanbul University Affiliated: No

Abstract

Objective: To investigate the efficacy and tolerability of mirtazapine combination with methylphenidate in young subjects with diagnosis of attention deficit hyperactivity disorder (ADHD) and comorbid anxiety or depressive disorders.